Organization Profile

You just read:

PneumRx, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial of RePneu Lung Volume Reduction Coil (RePneu LVRC) System

News provided by

PneumRx, Inc.

May 15, 2012, 07:01 ET